These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29624814)

  • 1. eIF2β, a subunit of translation-initiation factor EIF2, is a potential therapeutic target for non-small cell lung cancer.
    Tanaka I; Sato M; Kato T; Goto D; Kakumu T; Miyazawa A; Yogo N; Hase T; Morise M; Sekido Y; Girard L; Minna JD; Byers LA; Heymach JV; Coombes KR; Kondo M; Hasegawa Y
    Cancer Sci; 2018 Jun; 109(6):1843-1852. PubMed ID: 29624814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer.
    Kakumu T; Sato M; Goto D; Kato T; Yogo N; Hase T; Morise M; Fukui T; Yokoi K; Sekido Y; Girard L; Minna JD; Byers LA; Heymach JV; Coombes KR; Kondo M; Hasegawa Y
    Cancer Sci; 2017 Apr; 108(4):732-743. PubMed ID: 28165654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of eukaryotic translation initiation factor 6 on non-small cell lung cancer development and progression.
    Gantenbein N; Bernhart E; Anders I; Golob-Schwarzl N; Krassnig S; Wodlej C; Brcic L; Lindenmann J; Fink-Neuboeck N; Gollowitsch F; Stacher-Priehse E; Asslaber M; Gogg-Kamerer M; Rolff J; Hoffmann J; Silvestri A; Regenbrecht C; Reinhard C; Pehserl AM; Pichler M; Sokolova O; Naumann M; Mitterer V; Pertschy B; Bergler H; Popper H; Sattler W; Haybaeck J
    Eur J Cancer; 2018 Sep; 101():165-180. PubMed ID: 30077122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross talk between protein kinase CK2 and eukaryotic translation initiation factor eIF2beta subunit.
    Llorens F; Sarno S; Sarró E; Duarri A; Roher N; Meggio F; Plana M; Pinna LA; Itarte E
    Mol Cell Biochem; 2005 Jun; 274(1-2):53-61. PubMed ID: 16335529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma.
    Qiao Y; Chen J; Ma C; Liu Y; Li P; Wang Y; Hou L; Liu Z
    Cell Physiol Biochem; 2018; 51(1):1-10. PubMed ID: 30439711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Afatinib induces apoptosis in NSCLC without EGFR mutation through Elk-1-mediated suppression of CIP2A.
    Chao TT; Wang CY; Chen YL; Lai CC; Chang FY; Tsai YT; Chao CH; Shiau CW; Huang YC; Yu CJ; Chen KF
    Oncotarget; 2015 Feb; 6(4):2164-79. PubMed ID: 25537503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of adjuvant chemotherapy for non-small cell lung cancer assessed by metastatic potential associated with ACTN4.
    Miura N; Kamita M; Kakuya T; Fujiwara Y; Tsuta K; Shiraishi H; Takeshita F; Ochiya T; Shoji H; Huang W; Ohe Y; Yamada T; Honda K
    Oncotarget; 2016 May; 7(22):33165-78. PubMed ID: 27121206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling.
    Xu X; Jiang J; Yao L; Ji B
    Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDMX is a prognostic factor for non-small cell lung cancer and regulates its sensitivity to cisplatin.
    Zhao H; Xie YZ; Xing R; Sun M; Chi F; Zeng YC
    Cell Oncol (Dordr); 2017 Aug; 40(4):357-365. PubMed ID: 28567715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foxk2 inhibits non-small cell lung cancer epithelial-mesenchymal transition and proliferation through the repression of different key target genes.
    Chen S; Jiang S; Hu F; Xu Y; Wang T; Mei Q
    Oncol Rep; 2017 Apr; 37(4):2335-2347. PubMed ID: 28260088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methionine Aminopeptidase 2 as a Potential Therapeutic Target for Human Non-Small-Cell Lung Cancers.
    Shimizu H; Yamagishi S; Chiba H; Ghazizadeh M
    Adv Clin Exp Med; 2016; 25(1):117-28. PubMed ID: 26935506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.
    Shi R; Zhang C; Wu Y; Wang X; Sun Q; Sun J; Xia W; Dong G; Wang A; Jiang F; Xu L
    Oncotarget; 2017 Mar; 8(12):19768-19779. PubMed ID: 28423619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPC25 upregulation increases cancer stem cell properties in non-small cell lung adenocarcinoma cells and independently predicts poor survival.
    Chen J; Chen H; Yang H; Dai H
    Biomed Pharmacother; 2018 Apr; 100():233-239. PubMed ID: 29432994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
    Han Y; Tian H; Chen P; Lin Q
    Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide phosphoribosyltransferase: a potent therapeutic target in non-small cell lung cancer with epidermal growth factor receptor-gene mutation.
    Okumura S; Sasaki T; Minami Y; Ohsaki Y
    J Thorac Oncol; 2012 Jan; 7(1):49-56. PubMed ID: 22089115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.
    Zhu CQ; Popova SN; Brown ER; Barsyte-Lovejoy D; Navab R; Shih W; Li M; Lu M; Jurisica I; Penn LZ; Gullberg D; Tsao MS
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11754-9. PubMed ID: 17600088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CIP2A mediates erlotinib-induced apoptosis in non-small cell lung cancer cells without EGFR mutation.
    Wang CY; Chao TT; Chang FY; Chen YL; Tsai YT; Lin HI; Huang YC; Shiau CW; Yu CJ; Chen KF
    Lung Cancer; 2014 Aug; 85(2):152-60. PubMed ID: 24954871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD.
    Zhang Y; Xu X; Zhang M; Wang X; Bai X; Li H; Kan L; Zhou Y; Niu H; He P
    BMC Cancer; 2016 May; 16():315. PubMed ID: 27184257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting apoptosis by 1,2-diazole through regulation of EGFR, Bcl-2 and CDK-2 mediated signaling pathway in human non-small cell lung carcinoma A549 cells.
    Vinod Prabhu V; Elangovan P; Niranjali Devaraj S; Sakthivel KM
    Gene; 2018 Dec; 679():352-359. PubMed ID: 30218747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.